Inhibition of CCR5-Dependent HIV-1 Infection by Hairpin Ribozyme Gene Therapy against CC-Chemokine Receptor 5

By Feng Y.   Leavitt M.   Tritz R.   Duarte E.   Kang D.   Mamounas M.   Gilles P.   Wong-Staal F.   Kennedy S.   Merson J.   Yu M.   Barber J.R.  

Virology, Vol. 276, Iss. 2, 2000-10 ,pp. : 271-278

Elsevier

Access to resources Recommend Favorite

Relationship between Productive HIV-1 Infection of Macrophages and CCR5 Utilization

By Hung C.-S.   Pontow S.   Ratner L.  

Virology, Vol. 264, Iss. 2, 1999-11 ,pp. : 278-288

Elsevier

Access to resources Recommend Favorite

Reduced HIV-1 Infectability of CD4 + Lymphocytes from Exposed-Uninfected Individuals: Association with Low Expression of CCR5 and High Production of -Chemokines

By Paxton W.A.   Liu R.   Kang S.   Wu L.   Gingeras T.R.   Landau N.R.   Mackay C.R.   Koup R.A.  

Virology, Vol. 244, Iss. 1, 1998-04 ,pp. : 66-73

Elsevier

Access to resources Recommend Favorite

The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO⁺CD4⁺ T lymphocytes

By Holl V.   Schmidt S.   Aubertin A.-M.   Moog C.  

Archives of Virology, Vol. 152, Iss. 3, 2007-03 ,pp. : 507-518

Springer Publishing Company

Access to resources Recommend Favorite

Chemokine receptors and the clinical course of HIV-1 infection

By de Roda Husman A.-M.   Schuitemaker H.  

Trends in Microbiology, Vol. 6, Iss. 6, 1998-06 ,pp. : 244-249

Elsevier

Access to resources Recommend Favorite